#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thromboangiitis obliterans Hereditary neuropathic amyloidosis Inclusion body myositis Marginal zone lymphoma Congenital aplastic anaemia Haemophilia A with anti factor VIII Superficial vein thrombosis Myeloproliferative neoplasm Infertility male Corneal neovascularisation Meningitis meningococcal Hypoparathyroidism Paget's disease of the vulva Chronic inflammatory demyelinating polyradiculoneuropathy Dedifferentiated liposarcoma More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Basic Information Rhabdomyosarcoma Ehlers-Danlos syndrome – Diagnostics Adrenogenital syndrome Amyotrophic lateral sclerosis – Diagnostics Primary mediastinal large B-cell lymphoma – Basic Information Marginal zone lymphoma refractory – Treatment Familial haemophagocytic lymphohistiocytosis – Diagnostics Adrenocortical carcinoma – Treatment Mucopolysaccharidosis II – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Idarubicin Skb264 Liquid Paraffin 2-DEOXY-D-GLUCOSE Fluindione Bms-986458 Sotatercept Hydroxypropylbetadex Ponatinib Nivolumab Rosnilimab Melatonin Dobutamine Hydrochloride Ddcart‐Cd19 Abiraterone Vosilasarm Human Normal Immunoglobulin Bcmacp03 Mitapivat Methylprednisolone Acetate More therapies…

    Learn about Your Condition

    Ischaemic skin ulcer Amyotrophic lateral sclerosis Erythema migrans Hyperkalaemia Peripheral ischaemia Liposarcoma Cardiac failure chronic Vaginal infection Urinary tract infection Leukocyte adhesion deficiency Pharyngeal cancer stage III Drug use disorder Oesophageal cancer metastatic White matter lesion Bronchopulmonary aspergillosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Ticagrelor monotherapy vs ticagrelor plus acetylsalicylic acid in patients with myocardial infarction treated medically

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial infarction
    Investigated Drugs:
    • Ticagrelor
    • Acetylsalicylic Acid
    France

  • A study of SAR448851 with FLORQUINITAU (18F) to assess safety and effectiveness in early Alzheimer’s disease

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Florquinitau (18F)
    Germany Spain

  • A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Rozanolixizumab
    France Germany Greece Hungary Italy Poland +1

  • Phase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ly3484356
    • Fulvestrant
    Belgium France Hungary Ireland Poland Portugal +2

  • Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    Finland Germany Greece Hungary Italy Poland +1

  • Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • Durvalumab
    Denmark Estonia Finland Germany Lithuania The Netherlands +2
Previous Page
1 … 661 662 663 664 665 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!